A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies
Year: 2019
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funders: Celgene, Cancer Research UK
Awards: G3601372966, G662952953
OpenAlex ID: W2891958511
